Analyst Research

Report Title Price
Vexim SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Vexim SA Continues to Develop Its Business Across Europe by Setting up an Italian Subsidiary


Friday, 6 Jul 2012 02:00am EDT 

Vexim SA announced its incorporation of an Italian subsidiary (in Milan). Vexim already has a strong reputation in Italy and so creation of this subsidiary will help accelerate the commercial development of the company's flagship SpineJack product range on Italian soil. 

Latest Developments for Vexim SA

Latest Key Developments in Medical

Company Quote

Vexim SA
(ALVXM.PA)
10.57
-0.4 -3.65%
17 May 2013